LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,254 | 5,830 | 8,509 | 17,563 | 9,447 |
| Marketable Securities | N/A | N/A | N/A | N/A | 10,000 |
| TOTAL | $4,840 | $6,576 | $9,763 | $19,124 | $20,232 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 11 | 302 | 357 |
| Intangibles | 0 | 0 | 0 | 252 | 250 |
| TOTAL | $N/A | $N/A | $11 | $554 | $607 |
| Total Assets | $4,840 | $6,576 | $9,774 | $19,678 | $20,839 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 5,933 |
| Accounts payable and accrued liabilities | 125 | 692 | 2,790 | 9,771 | 4,626 |
| Accrued Expenses | 496 | 333 | 1,004 | 3,070 | 6,514 |
| TOTAL | $621 | $1,025 | $3,836 | $13,007 | $17,236 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 149 | 179 |
| TOTAL | $N/A | $N/A | $N/A | $181 | $213 |
| Total Liabilities | $621 | $1,025 | $3,836 | $13,188 | $17,449 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,723 | 65,723 | 65,723 | 65,723 | 55,550 |
| Common Shares | 7 | 657 | 657 | 657 | 555 |
| Retained earnings | -424,321 | -422,680 | -421,982 | -419,939 | -415,687 |
| TOTAL | $4,219 | $5,551 | $5,938 | $6,490 | $3,390 |
| Total Liabilities And Equity | $4,840 | $6,576 | $9,774 | $19,678 | $20,839 |